|
|
| Model Number |
N/A |
| Medical Device Problem Code |
Material Rupture (1546)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
08/11/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A 5mm x 10cm 90cm saber percutaneous transluminal angioplasty (pta) balloon catheter ruptured within nominal pressure during use for a shunt pta case.Therefore, it was replaced with another unknown balloon catheter.The device was stored and flushed as per instruction for use (ifu).The 99% occluded lesion had severe vessel tortuosity.It was not considered a chronic total occlusion (cto).The access site was the radial artery.There was no difficulty removing the product from the forming tube, no difficulty removing the protective sheath from the needle and no difficulty removing any of the sterile packaging components.There were no kinks or other damages noted prior to inserting the product the product into the patient.The device prepped normally.The same indeflator was used successfully with other devices.There was no resistance/friction while inserting the balloon through the rotating hemostatic valve and no resistance/friction while inserting the balloon through the guide catheter.There was no difficulty advancing the balloon catheter through the vessel, no difficulty crossing the lesion and the catheter was never in an acute bend.The maximum inflation pressure was 8 atmospheres.There was no leakage noted from the balloon, shaft, hub, or an unknown segment.The device easily removed and was intact upon removal.There was no reported patient injury.The device was not returned for analysis.A product history record (phr) review of lot 82170158 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿balloon-burst - at/below rbp¿ could not be confirmed and the exact root cause could not be determined.Handling and procedural factors such as vessel characteristics of 99% stenosis and severe vessel tortuosity, may have contributed to the reported event.Arteriovenous shunts are often scarred and fibrous in nature and therefore often resistant to balloon expansion increasing the likelihood of damage to the balloon.However, without the return of the device for analysis it is difficult to draw a clinical conclusion between the device and the event reported.According to the warnings in the safety information in the instructions for use ¿prior to angioplasty, the catheter should be examined to verify functionality and integrity, and ensure that its size and shape are suitable for the specific procedure for which it is to be used.Do not use if product damage is suspected or evident.To reduce the potential for vessel damage or the risk of dislodgement of particles it is very important that the inflated diameter of the balloon should approximate the diameter of the vessel just proximal and distal to the lesion.The balloon dimensions are printed on the product label.The compliance table incorporated with the product shows how balloon diameter increases as pressure increases.Do not exceed the rated burst pressure recommended on the label.The rated burst pressure is based on the results of in vitro testing.At least 99.9% of the balloons (with a 95% confidence) will not burst at or below their rated burst pressure.Use of a pressure monitoring device is recommended to prevent over-pressurization.Pressure in excess of the rated burst pressure can cause balloon rupture and potential inability to withdraw the catheter through the introducer sheath.Balloon rupture can cause vessel damage and the need for additional intervention.Use only the recommended balloon inflation medium (a 50/50 mixture by volume of contrast medium and normal saline).Never use air or any gaseous medium to inflate the balloon.¿ neither the phr review nor the information available suggests a design or manufacturing related cause could be related to the manufacturing process of the unit.Therefore, no corrective or preventive actions will be taken.
|
| |
|
Event or Problem Description
|
|
A 5mm x 10cm 90cm saber percutaneous transluminal angioplasty (pta) balloon catheter ruptured within nominal pressure during use for a shunt pta case.Therefore, it was replaced with another unknown balloon catheter.There was no reported patient injury.The device was stored and flushed as per instruction for use (ifu).The 99% occluded lesion had severe vessel tortuosity.It was not considered a chronic total occlusion (cto).The access site was the radial artery.There was no difficulty removing the product from the forming tube, no difficulty removing the protective sheath from the needle and no difficulty removing any of the sterile packaging components.There were no kinks or other damages noted prior to inserting the product the product into the patient.The device prepped normally.The same indeflator was used successfully with other devices.There was no resistance/friction while inserting the balloon through the rotating hemostatic valve and no resistance/friction while inserting the balloon through the guide catheter.There was no difficulty advancing the balloon catheter through the vessel, no difficulty crossing the lesion and the catheter was never in an acute bend.The maximum inflation pressure was 8 atmospheres.There was no leakage noted from the balloon, shaft, hub, or an unknown segment.The device easily removed and was intact upon removal.Additional patient and procedural details were requested but were unknown.The device will not be returned for evaluation due to covid-19.
|
| |
|
Search Alerts/Recalls
|
|
|